BIOMAT Database Logo BIOMAT Database Logo

[Role of plasminogen binding site of alpha 2-plasmin inhibitor on the initiation and regulation of fibrinolysis]. 1989

M Iwamoto, and N Sugiyama

UI MeSH Term Description Entries
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000979 alpha-2-Antiplasmin A member of the serpin superfamily found in plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin. alpha 2-Plasmin Inhibitor,Serpin F2,alpha(2)-Plasmin Inhibitor,alpha-2 Antiplasmin,alpha 2 Antiplasmin,alpha 2 Plasmin Inhibitor
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

M Iwamoto, and N Sugiyama
Identification of the plasminogen-binding site of human alpha 2-plasmin inhibitor.
June 1986, Journal of biochemistry,
M Iwamoto, and N Sugiyama
The initiation of fibrinolysis in alpha 2-plasmin inhibitor deficient plasma. Role of fibrin.
March 1986, Thrombosis research,
M Iwamoto, and N Sugiyama
Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex.
October 1994, Thrombosis research,
M Iwamoto, and N Sugiyama
Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
September 1985, The American journal of medicine,
M Iwamoto, and N Sugiyama
Histidine-rich glycoprotein and alpha 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin.
February 1984, Thrombosis research,
M Iwamoto, and N Sugiyama
Influence of alpha 2-plasmin inhibitor on adsorption of plasminogen to fibrin.
January 1980, Thrombosis research,
M Iwamoto, and N Sugiyama
Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency.
November 1983, Blood,
M Iwamoto, and N Sugiyama
Plasmin-alpha 2-plasmin inhibitor complex and alpha 2-plasmin inhibitor in chronic subdural hematoma.
January 1989, Journal of neurosurgery,
M Iwamoto, and N Sugiyama
Acceleration of fibrinolysis by the N-terminal peptide of alpha 2-plasmin inhibitor.
July 1985, Blood,
M Iwamoto, and N Sugiyama
[Alpha 2-plasmin inhibitor-plasmin complex].
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!